AmerisourceBergen raises FY13 continuing ops EPS view to $3.04-$3.14 Previous view was $2.96-$3.06. Consensus is $3.08. Due to the impact of the sale, AmerisourceBergen has revised its financial performance expectations for FY13. The company now expects revenue growth in the range of 8%-10%, consensus $86.17B. The revised EPS range does not include the impact of significant one-time expenses anticipated as a result of the previously disclosed new strategic long-term relationship with Walgreen Co. and Alliance Boots, GmbH, including a LIFO expense due to an anticipated inventory build and recurring non-cash expenses relating to the equity warrants issued in connection with the new relationship. The company continues to expect free cash flow in the range of $100M-$200M, and to repurchase approximately $400M of common stock in FY13.
UBS to hold a conference Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link